These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 20606310

  • 1. A nonlinear mixed effects modelling analysis of topiramate pharmacokinetics in patients with epilepsy.
    Vovk T, Jakovljević MB, Kos MK, Janković SM, Mrhar A, Grabnar I.
    Biol Pharm Bull; 2010; 33(7):1176-82. PubMed ID: 20606310
    [Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetics of topiramate in adult patients with epilepsy using nonlinear mixed effects modelling.
    Jovanović M, Sokić D, Grabnar I, Vovk T, Prostran M, Vučićević K, Miljković B.
    Eur J Pharm Sci; 2013 Nov 20; 50(3-4):282-9. PubMed ID: 23891703
    [Abstract] [Full Text] [Related]

  • 3. Population Pharmacokinetics of Topiramate in Japanese Pediatric and Adult Patients With Epilepsy Using Routinely Monitored Data.
    Takeuchi M, Yano I, Ito S, Sugimoto M, Yamamoto S, Yonezawa A, Ikeda A, Matsubara K.
    Ther Drug Monit; 2017 Apr 20; 39(2):124-131. PubMed ID: 28230619
    [Abstract] [Full Text] [Related]

  • 4. Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis.
    Bae EK, Lee J, Shin JW, Moon J, Lee KJ, Shin YW, Kim TJ, Shin D, Jang IJ, Lee SK.
    Seizure; 2016 Apr 20; 37():8-12. PubMed ID: 26908152
    [Abstract] [Full Text] [Related]

  • 5. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M, Riva R, Albani F, Avoni P, Baruzzi A.
    Ther Drug Monit; 2002 Jun 20; 24(3):332-7. PubMed ID: 12021622
    [Abstract] [Full Text] [Related]

  • 6. Influence of dosage, age, and co-medication on plasma topiramate concentrations in children and adults with severe epilepsy and preliminary observations on correlations with clinical response.
    Ferrari AR, Guerrini R, Gatti G, Alessandrì MG, Bonanni P, Perucca E.
    Ther Drug Monit; 2003 Dec 20; 25(6):700-8. PubMed ID: 14639056
    [Abstract] [Full Text] [Related]

  • 7. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
    Clark AM, Kriel RL, Leppik IE, White JR, Henry TR, Brundage RC, Cloyd JC.
    Epilepsia; 2013 Jun 20; 54(6):1106-11. PubMed ID: 23586686
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
    Johannessen Landmark C, Baftiu A, Tysse I, Valsø B, Larsson PG, Rytter E, Johannessen SI.
    Ther Drug Monit; 2012 Aug 20; 34(4):440-5. PubMed ID: 22777154
    [Abstract] [Full Text] [Related]

  • 9. Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data.
    Battino D, Croci D, Rossini A, Messina S, Mamoli D, Perucca E.
    Clin Pharmacokinet; 2005 Aug 20; 44(4):407-16. PubMed ID: 15828853
    [Abstract] [Full Text] [Related]

  • 10. A study of topiramate pharmacokinetics and tolerability in children with epilepsy.
    Rosenfeld WE, Doose DR, Walker SA, Baldassarre JS, Reife RA.
    Pediatr Neurol; 1999 May 20; 20(5):339-44. PubMed ID: 10371378
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy.
    Rosenfeld WE, Liao S, Kramer LD, Anderson G, Palmer M, Levy RH, Nayak RK.
    Epilepsia; 1997 Mar 20; 38(3):324-33. PubMed ID: 9070595
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
    Manitpisitkul P, Shalayda K, Todd M, Wang SS, Ness S, Ford L.
    Epilepsia; 2013 Jan 20; 54(1):156-64. PubMed ID: 23157581
    [Abstract] [Full Text] [Related]

  • 13. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C, De Smedt H, Stockis A.
    Epilepsia; 2007 Nov 20; 48(11):2111-5. PubMed ID: 17651416
    [Abstract] [Full Text] [Related]

  • 14. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E, Cloyd J, Critchley D, Fuseau E.
    Epilepsia; 2008 Jul 20; 49(7):1123-41. PubMed ID: 18503564
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
    Girgis IG, Nandy P, Nye JS, Ford L, Mohanty S, Wang S, Ochalski S, Eerdekens M, Cox E.
    Epilepsia; 2010 Oct 20; 51(10):1954-62. PubMed ID: 20880232
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic interactions between topiramate and pioglitazone and metformin.
    Manitpisitkul P, Curtin CR, Shalayda K, Wang SS, Ford L, Heald D.
    Epilepsy Res; 2014 Nov 20; 108(9):1519-32. PubMed ID: 25219351
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic interactions of topiramate.
    Bialer M, Doose DR, Murthy B, Curtin C, Wang SS, Twyman RE, Schwabe S.
    Clin Pharmacokinet; 2004 Nov 20; 43(12):763-80. PubMed ID: 15355124
    [Abstract] [Full Text] [Related]

  • 18. Plasma concentration of topiramate correlates with cerebrospinal fluid concentration.
    Christensen J, Højskov CS, Dam M, Poulsen JH.
    Ther Drug Monit; 2001 Oct 20; 23(5):529-35. PubMed ID: 11591899
    [Abstract] [Full Text] [Related]

  • 19. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
    Mimrod D, Specchio LM, Britzi M, Perucca E, Specchio N, La Neve A, Soback S, Levy RH, Gatti G, Doose DR, Maryanoff BE, Bialer M.
    Epilepsia; 2005 Jul 20; 46(7):1046-54. PubMed ID: 16026556
    [Abstract] [Full Text] [Related]

  • 20. Age and antiepileptic drugs influence topiramate plasma levels in children.
    Dahlin MG, Ohman IK.
    Pediatr Neurol; 2004 Oct 20; 31(4):248-53. PubMed ID: 15464635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.